
12.65 BATS BZX Real-Time Price As of Aug 09 | ![]() Today’s Change | 7.50 Today|||52-Week Range 29.30 | -38.74% Year-to-Date |
Wall Street Analysts Believe Alector (ALEC) Could Rally 58%: Here's is How to Trade Aug 09 / Zacks.com - Paid Partner Content | Alector (ALEC) Q2 Earnings and Revenues Beat Estimates Aug 04 / Zacks.com - Paid Partner Content |
Previous close | 12.65 |
Today’s open | 12.85 |
Day’s range | 12.48 - 13.16 |
Volume | 26,429 |
Average volume (3 months) | 633,653 |
Market cap | $1.1B |
Earnings growth (last year) | +81.53% |
Earnings growth (this year) | -259.73% |
Earnings growth (next 5 years) | -49.85% |
Revenue growth (last year) | +881.54% |
P/E ratio | 26.4 |
Price/Sales | 8.02 |
Price/Book | 3.54 |
Today’s change | Today’s % change | |
---|---|---|
RCKTRocket Pharmaceutica... | +0.54 | +3.33% |
SRNESorrento Therapeutic... | +0.05 | +1.92% |
CDMOAvid Bioservices Inc | 0.00 | 0.00% |
REPLReplimune Group Inc | 0.00 | 0.00% |
Next reporting date | November 15, 2022 |
EPS forecast (this quarter) | -$0.48 |
Annual revenue (last year) | $207.1M |
Annual profit (last year) | -$36.3M |
Net profit margin | -17.54% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |